MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Income Overview

Net Income
-$14,610,000
Unit: Dollar

Income Statement
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Revenues
0 0 0 0
Research and development
5,378,000 5,118,000 3,738,000 3,600,000
General and administrative
2,488,000 2,407,000 2,147,000 2,091,000
Depreciation and amortization
8,000 9,000 21,000 29,000
Total operating expenses
7,874,000 7,534,000 5,906,000 5,720,000
Loss from operations
-7,874,000 -7,534,000 -5,906,000 -5,720,000
Gain from change in fair value of warrant liability
-10,770,000 -4,187,000 -1,591,000 -9,609,000
Transaction costs allocated to warrant liabilities
693,000 -2,118,000 530,000 1,207,000
Loss on extinguishment of warrant liabilities
NaN -614,000 NaN NaN
Gain on issuance of warrant liabilities
-15,158,000 7,797,000 -20,609,000 -10,352,000
Other income, net
76,000 -49,000 16,000 4,000
Interest income, net
34,000 10,000 39,000 26,000
Net gain
-12,845,000 5,915,000 -25,399,000 -7,640,000
Foreign currency translation
NaN NaN -6,000 0
Warrant deemed dividend
1,765,000 101,000 NaN NaN
Comprehensive loss
NaN NaN -25,405,000 -7,640,000
Net loss available to common stockholders
-14,610,000 5,814,000 NaN NaN
Basic EPS
-3.54 4.908 -0.68 -0.49
Basic Average Shares
4,124,482 1,184,569* 37,304,455 15,526,401
Unit: Dollar. Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

Net loss availableto common...-$14,610,000 Net gain-$12,845,000 (-99.58%↓ Y/Y)Warrant deemed dividend$1,765,000 Gain from change infair value of warrant...-$10,770,000 (-18.95%↓ Y/Y)Other income, net$76,000 (744.44%↑ Y/Y)Interest income, net$34,000 (13.33%↑ Y/Y)Gain on issuance ofwarrant liabilities-$15,158,000 (-94.38%↓ Y/Y)Loss from operations-$7,874,000 (-32.49%↓ Y/Y)Transaction costs allocatedto warrant...$693,000 (-61.24%↓ Y/Y)Total operatingexpenses$7,874,000 (32.49%↑ Y/Y)Research and development$5,378,000 (56.56%↑ Y/Y)General andadministrative$2,488,000 (0.44%↑ Y/Y)Depreciation andamortization$8,000 (-74.19%↓ Y/Y)

Moleculin Biotech, Inc. (MBRX)

Moleculin Biotech, Inc. (MBRX)